Board of Directors
Jay LeCoque
Executive Chairman and CEOJay has over 25 years of senior management experience focused on global healthcare diagnostics and clinical life sciences. Jay is the current CEO and Executive Chairman of Source BioScience since being appointed in 2017. He was an Executive Director of Bioquell plc from 2016 until its acquisition by ECOLAB in 2019. Prior to that, he was CEO of Celsis International plc from 2000 to 2009, and remained CEO following a public to private transaction in 2009 to form Celsis International Ltd until its acquisition in 2015. Jay earned a BS in Business Administration and Marketing from Miami of Ohio University and his MBA from Northwestern University Kellogg School of Management.
Kirsten Lund
CFO and Company SecretaryKirsten Lund oversees all financial strategy, planning, and operations for Tissue Regenix. With more than 15 years of finance experience, she brings deep expertise in financial leadership and strategic business growth.
Kirsten joined Tissue Regenix in 2010 and has progressed through several senior roles within the company. She served as Group Financial Controller for three years before being appointed Group Finance Director in November 2019, a position she held until January 2022. She then transitioned to EMEA Director, working closely with the management team to help drive the company’s strategic expansion into new markets.
Drawing on her extensive experience in the healthcare sector, Kirsten provides invaluable insight into company structure and routes to market.
Kirsten holds a Bachelor of Science degree from the University of Derby and achieved her ACCA qualification in 2015.
Judy Madden
COOJudy has over 25 years of senior management experience in commercial and operations management in global life science companies. She held senior management roles at Charles River Laboratories from 2015 though 2024 including Executive Director of Celsis, and General Manager of Accugenix. Judy was Vice President, Corporate Development for Celsis international prior to its acquisition by Charles River in 2015. Prior to that she served in senior marketing and product development roles at medical device maker, Advanced Bionics.
Judy holds a HBA degree in Marketing and Business Administration from Ivey Business School at Western University in London, Canada.